arrow
S

Stephan Singer

department of general and molecular pathology and pathological anatomy
H指数:36
被引数:4,148

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

NUP153 immunoreactivity in neuroendocrine neoplasms supports the diagnosis of NET versus NEC and is modulated by post-translational modifications

NUP153免疫反应性在神经内分泌肿瘤中支持NET与NEC的诊断区分,并受翻译后修饰的调节

2026-08-200
OAAI
Personalized signaling pathway analysis of gastrointestinal tumors for patient stratification and drug target evaluation using clinically derived core biopsies

基于临床来源核心活检的胃肠道肿瘤个性化信号通路分析,用于患者分层和药物靶点评估

2026-02-250
OAAI
Clinical outcome of biomarker-guided therapies in adult neuro-oncology patients: An update from the Tubingen molecular tumor board cohort

成人神经肿瘤患者生物标志物指导治疗的临床结局:图宾根分子肿瘤委员会队列的更新

2026-01-010
PRE
Endoscopic retrograde cholangiopancreatography as a diagnostic key tool for biliary atresia: feasibility, safety and accuracy in neonates with cholestatic liver disease

内镜逆行胆胰管造影作为诊断胆道闭锁的关键工具:在伴有胆汁淤积性肝病的新生儿中的可行性、安全性和准确性

2025-12-130
OAAI
Results of the First Folate Receptor Alpha Testing Trial by the German Quality Assurance Initiative in Pathology (QuIP®)

德国病理学质量保证倡议(QuIP®)首次叶酸受体α检测试验的结果

2025-11-190
OAAI
DNA methylation patterns facilitate tracing the origin of neuroendocrine neoplasms

DNA甲基化模式有助于追踪神经内分泌肿瘤的起源

2025-10-270
OAAI
Accurate MS-based diagnostic amyloid typing using endogenously normalized protein intensities in formalin-fixed paraffin-embedded tissue

基于内源性标准化蛋白强度的FFPE组织MS诊断性淀粉样蛋白分型

2025-07-210
OAAI
Case Report: FGFR2 inhibitor resistance via PIK3CA and CDKN2A/B in an intrahepatic cholangiocarcinoma patient with FGFR2-SH3GLB1 fusion

病例报告: FGFR2-SH3GLB1融合的肝内胆管癌患者通过PIK3CA和CDKN2A/B对FGFR2抑制剂耐药

2025-04-070
OAAI
An AI-assisted morphoproteomic approach is a supportive tool in esophagitis-related precision medicine

AI辅助形态蛋白质组学方法是一种食管炎相关精准医学的支持性工具。

2025-02-030
OA